Search results
New mechanism of immune evasion in squamous cell carcinoma offers potential for improved treatment
Medical Xpress· 2 days agoA research group has revealed the tumor-extrinsic function of master regulator transcription...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Laryngeal cancer metastasis sites, symptoms, and treatment
Medical News Today· 3 days agoLaryngeal cancer may spread to cartilage, soft tissues, or lymph nodes in the neck area and to more...
Seneca Park Zoo provides update on Kipenzi after cancer diagnosis
WROC Rochester· 4 days agoROCHESTER, N.Y. (WROC) — The Seneca Park Zoo has released an update on Kipenzi, a Masai giraffe who...
High-Stage cSCC: Outcomes Superior With Mohs vs WLE
Medscape· 3 days agoMohs surgery appears to be superior to wide local excision (WLE) in patients with high-stage cutaneous squamous cell carcinoma (cSCC) ...
The Current State Of Skin Cancer
Women s Health· 3 days agoThe American Academy of Dermatology also points out that the rates of melanoma in people under 50 are higher in women than in men. “The incidence of...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 4 Kansas City· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor...
Protect your skin in the sun: A warning during Skin Cancer Awareness month
ABC 3340 Birmingham· 4 days agoAccording to the Skin Cancer Foundation 1 in 5 Americans will have skin cancer before the age of 70....
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 3 days agoIn November last year, the company concluded the subject enrolment in the Phase III BURAN trial of...